Skip to main content

Site notifications

We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.

Sub menu

News and events
Contact us
About us

Search

Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

You are here

Home
Resources and guidance
Sponsors

Qiagen Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (44)
ARTG (23)
COVID-19 test kit (4)

Date

2026 (1)
2025 (1)
2024 (22)
2023 (8)
2022 (4)
2021 (5)
2020 (4)
2019 (9)
2018 (1)
2017 (3)
2016 (3)
2015 (5)
2014 (3)
2013 (2)

Search

Sponsor content

71 result(s) found, displaying 11 to 20

Qiagen Pty Ltd - Infectious disease IVDs (422431)

25 September 2023

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Qiagen Pty Ltd - Infectious disease IVDs.
Qiagen Pty Ltd - Human papilloma virus IVDs Cancelled under Section 41GL(d) of the Act

24 June 2024

Cancellation by sponsor

Requested by Qiagen Pty Ltd
Qiagen Pty Ltd - General laboratoryware IVDs Cancelled under Section 41GL(d) of the Act

24 June 2024

Cancellation by sponsor

Requested by Qiagen Pty Ltd
Qiagen Pty Ltd - Multiple-viruses IVDs Cancelled under Section 41GL(d) of the Act

24 June 2024

Cancellation by sponsor

Requested by Qiagen Pty Ltd
Qiagen Pty Ltd - Multiple infectious organism IVDs Cancelled under Section 41GL(d) of the Act

24 June 2024

Cancellation by sponsor

Requested by Qiagen Pty Ltd
Qiagen Pty Ltd - Viral infectious disease IVDs Cancelled under Section 41GL(d) of the Act

24 June 2024

Cancellation by sponsor

Requested by Qiagen Pty Ltd
Qiagen Pty Ltd - Severe acute respiratory syndrome-associated coronavirus IVDs Cancelled under Section 41GL(d) of the Act

24 June 2024

Cancellation by sponsor

Requested by Qiagen Pty Ltd
Qiagen Pty Ltd - Instrument/analyser IVDs Cancelled under Section 41GL(d) of the Act

24 June 2024

Cancellation by sponsor

Requested by Qiagen Pty Ltd
Qiagen Pty Ltd - Software IVDs Cancelled under Section 41GL(d) of the Act

24 June 2024

Cancellation by sponsor

Requested by Qiagen Pty Ltd
Qiagen Pty Ltd - Hepatitis C virus IVDs Cancelled under Section 41GL(d) of the Act

24 June 2024

Cancellation by sponsor

Requested by Qiagen Pty Ltd

Pages

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

© Commonwealth of Australia